News - 23 Mar `24France Approves Compassionate Vitiligo Treatment with Protopic

New

France Approves Compassionate Vitiligo Treatment with Protopic

On March 21, 2024, French health authorities granted special permission for doctors to prescribe Protopic 0.1% (Tacrolimus) for treating vitiligo in adults and children over 2 years old. This kind of permission is given when there's already a different approved treatment available, but this ointment might better meet some patients' needs.

Companies Pierre Fabre Médicament and Léo Pharma A/S that make this ointment must follow certain rules for using it and keeping track of how it's working. This includes regular updates to a health monitoring center in Toulouse and providing summaries of how the treatment is going.

This special permission is set for three years from the day after the decision was announced on the ANSM website. The director general of the health authority, Christelle Ratignier-Carbonneil, signed off on this decision.

Vitiligo Treatment With Protopic Tacrolimus Approved 2024

 

 



      FAQOther Questions

      • Will it spread?

        Vitiligo is famously unpredictable, but it doesn't move at random. By looking at thousands of cases, researchers have identified specific patterns of how the condition behaves. ...

      • Which skin conditions can be mistaken for vitiligo?

        Vitiligo is a common skin condition with characteristic milky white patches of irregular shape. However, several other skin conditions exhibit similar symptoms that can lead to ...

      • What are the best predictors for therapy response in vitiligo?

        A fair question. Also a slightly annoying one, because dermatology loves nuance and patients usually want something more like a weather forecast. Still, a few factors do show up...